Ocular Therapeutix, Inc. (OCUL)
NASDAQ: OCUL · Real-Time Price · USD
9.99
-0.15 (-1.48%)
At close: Sep 18, 2026, 4:00 PM EDT
10.08
+0.09 (0.90%)
After-hours: Sep 18, 2026, 7:30 PM EDT
Ocular Therapeutix Employees
Ocular Therapeutix had 325 employees as of December 31, 2025. The number of employees increased by 51 or 18.61% compared to the previous year.
Employees
325
Change (1Y)
51
Growth (1Y)
18.61%
Revenue / Employee
$160,169
Profits / Employee
-$927,529
Market Cap
2.19B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 325 | 51 | 18.61% |
| Dec 31, 2024 | 274 | 7 | 2.62% |
| Dec 31, 2023 | 267 | -7 | -2.55% |
| Dec 31, 2022 | 274 | 46 | 20.18% |
| Dec 31, 2021 | 228 | 47 | 25.97% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Sarepta Therapeutics | 835 |
| Nuvation Bio | 305 |
| UroGen Pharma | 300 |
| Biohaven | 274 |
| Zenas BioPharma | 167 |
| Aurinia Pharmaceuticals | 128 |
| Nektar Therapeutics | 63 |
| Trevi Therapeutics | 34 |
OCUL News
- 2 days ago - Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 5 days ago - Ocular Therapeutix Transcript: 2026 Global Healthcare Conference - Transcripts
- 5 days ago - Ocular Therapeutix completes pre-NDA meeting with FDA for Axpaxli - TheFly
- 5 days ago - Ocular Therapeutix™ Announces Positive Pre-NDA Meeting with U.S. FDA for AXPAXLI™ in Wet AMD - GlobeNewsWire
- 19 days ago - Ocular Therapeutix™ to Participate in September and October Investor and Scientific Conferences - GlobeNewsWire
- 22 days ago - Ocular Therapeutix Slides: Investor presentation - Filings
- 23 days ago - Ocular Therapeutix Slides: Study presentation - Filings
- 24 days ago - Ocular Therapeutix Slides: Corporate presentation - Filings